More articles from News in Depth

Microbiota Manipulated to Enhance Anticancer Immunity
Cancer Discovery May 2019, DOI: 10.1158/2159-8290.CD-ND2019-004
Targeting MCL1, Companies Aim to Unblock Apoptosis
Cancer Discovery May 2019, 9 (5) 572; DOI: 10.1158/2159-8290.CD-ND2019-002
Understanding Hyperprogression in Cancer
Cancer Discovery Apr 2019, DOI: 10.1158/2159-8290.CD-ND2019-003
PD-1 Blockade in GBM: Uncovering Response Clues
Cancer Discovery Apr 2019, DOI: 10.1158/2159-8290.CD-ND2019-001
A Deep Dive into Immunotherapy Resistance
Cancer Discovery Jan 2019, 9 (1) 10; DOI: 10.1158/2159-8290.CD-ND2018-010
A Rethink for IO Biomarkers
Cancer Discovery Nov 2018, 8 (11) 1342; DOI: 10.1158/2159-8290.CD-ND2018-009
CAR T-cell Therapy for Solid Tumors?
Cancer Discovery Nov 2018, 8 (11) 1341; DOI: 10.1158/2159-8290.CD-ND2018-008
Companies Scaling Back IDO1 Inhibitor Trials
Cancer Discovery Jul 2018, 8 (7) OF5; DOI: 10.1158/2159-8290.CD-ND2018-007
The Quest for Off-the-Shelf CAR T Cells
Cancer Discovery Jul 2018, 8 (7) 787-788; DOI: 10.1158/2159-8290.CD-ND2018-005
Warming “Cold” Melanoma with TLR9 Agonists
Cancer Discovery Jun 2018, 8 (6) 670; DOI: 10.1158/2159-8290.CD-ND2018-004

Main menu